国际药物开发与研究杂志

  • 国际标准期刊号: 0975-9344
  • 期刊 h 指数: 44
  • 期刊引用分数: 59.93
  • 期刊影响因子: 48.80
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Drug Discovery and Development for Diseases

Yasser Ogrim

New models of medication disclosure have been created to beat the absence of present day and powerful medications for ignored illnesses, for example, human African trypanosomiasis (HAT; dozing disorder), leishmaniasis, and Chagas sickness, which have no monetary practicality for the drug business. Fully intent on consolidating the abilities and exploration limit in scholarly community, drug industry, and agreement specialists, public–private associations or item improvement organizations expect to make centered examination consortia that address all parts of medication disclosure and advancement.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证